MedTrace Logo

An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

NCT01725646 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2014-05-19

No results posted yet for this study

Summary

1. Evaluation of the efficacy of Omacor® in Taiwanese hypertriglyceridemia patients
2. Evaluation of the safety of Omacor® in Taiwanese hypertriglyceridemia patients

Conditions

  • Hypertriglyceridemia

Interventions

DRUG

Omacor®

Subjects in 4 g and 2 g Omacor® will take this drug

DRUG

Placebo

Subjects in placebo group will take this drug

Sponsors & Collaborators

  • Excelsior

    lead INDUSTRY

Principal Investigators

  • Chuen-Den Tseng, M.D., PhD. · NTUH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-07-31
Completion
2013-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01725646 on ClinicalTrials.gov